Involvement	O
of	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
pathways	O
in	O
interleukin-8	B-protein
production	O
by	O
human	B-cell_type
monocytes	I-cell_type
and	O
polymorphonuclear	B-cell_type
cells	I-cell_type
stimulated	O
with	O
lipopolysaccharide	O
or	O
Mycoplasma	B-protein
fermentans	I-protein
membrane	I-protein
lipoproteins	I-protein
.	O

Interleukin-8	B-protein
(	O
IL-8	B-protein
)	O
is	O
a	O
chemokine	B-protein
that	O
belongs	O
to	O
the	O
alpha-chemokine	B-protein
or	O
CXC	B-protein
subfamily	I-protein
and	O
is	O
produced	O
by	O
a	O
wide	O
variety	O
of	O
human	O
cells	O
,	O
including	O
monocytes	B-cell_type
and	O
polymorphonuclear	B-cell_type
cells	I-cell_type
(	O
PMN	B-cell_type
)	O
.	O

IL-8	B-protein
is	O
secreted	O
in	O
response	O
to	O
inflammatory	O
stimuli	O
,	O
notably	O
bacterial	O
products	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
mechanisms	O
by	O
which	O
these	O
agents	O
mediate	O
IL-8	B-protein
induction	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
Mycoplasma	B-protein
fermentans	I-protein
lipid-associated	I-protein
membrane	I-protein
proteins	I-protein
(	O
LAMPf	B-protein
)	O
induce	O
the	O
production	O
of	O
high	O
levels	O
of	O
IL-8	B-protein
by	O
THP-1	B-cell_line
(	I-cell_line
human	I-cell_line
monocyte	I-cell_line
)	I-cell_line
cells	I-cell_line
and	O
PMN	B-cell_type
at	O
the	O
same	O
extent	O
as	O
LPS	O
.	O

It	O
was	O
previously	O
demonstrated	O
that	O
stimulation	O
of	O
monocytic	O
cells	O
with	O
either	O
LPS	O
or	O
LAMPf	B-protein
led	O
to	O
a	O
series	O
of	O
common	O
downstream	O
signaling	O
events	O
,	O
including	O
the	O
activation	O
of	O
protein	B-protein
tyrosine	I-protein
kinase	I-protein
and	O
of	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
cascades	O
.	O

By	O
using	O
PD-98059	O
and	O
SB203580	O
,	O
two	O
potent	O
and	O
selective	O
inhibitors	O
of	O
MEK1	B-protein
(	O
a	O
kinase	B-protein
upstream	O
of	O
ERK1/2	B-protein
)	O
and	O
p38	B-protein
,	O
respectively	O
,	O
we	O
have	O
demonstrated	O
that	O
both	O
ERK1/2	O
and	O
p38	O
cascades	O
play	O
a	O
key	O
role	O
in	O
the	O
production	O
of	O
IL-8	B-protein
by	O
monocytes	B-cell_type
and	O
PMN	B-cell_type
stimulated	O
with	O
bacterial	O
fractions	O
.	O

INFECTION	NULL
AND	NULL
IMMUNITY	NULL
,	NULL
Feb.	NULL
1999	NULL
,	NULL
p.	NULL
688-693	NULL
0019-9567/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

67	NULL
,	NULL
No	NULL
.	NULL

2	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Involvement	NULL
of	NULL
Mitogen-Activated	NULL
Protein	NULL
Kinase	NULL
Pathways	NULL
in	NULL
Interleukin-8	NULL
Production	NULL
by	NULL
Human	NULL
Monocytes	NULL
and	NULL
Polymorphonuclear	NULL
Cells	NULL
Stimulated	NULL
with	NULL
Lipopolysaccharide	NULL
or	NULL
Mycoplasma	NULL
fermentans	NULL
Membrane	NULL
Lipoproteins	NULL
CHRISTELLE	NULL
MARIE	NULL
,	NULL
SERGIO	NULL
ROMAN-ROMAN	NULL
,	NULL
``	NULL
anp	NULL
GEORGES	NULL
RAWADP*	NULL
Unité	NULL
d	NULL
'Immuno-Allergie	NULL
'	NULL
and	NULL
Département	NULL
de	NULL
Bactériologie	NULL
et	NULL
de	NULL
Mycologie	NULL
,	NULL
Laboratoire	NULL
des	NULL
Mycoplasmes	NULL
,	NULL
``	NULL
Paris	NULL
75724	NULL
Cedex	NULL
15	NULL
,	NULL
and	NULL
Centre	NULL
de	NULL
Recherche	NULL
Romainville	NULL
,	NULL
Hoechst-Marion-Roussel	NULL
,	NULL
93230	NULL
Romainville	NULL
Cedex	NULL
,	NULL
``	NULL
France	NULL
Received	NULL
27	NULL
October	NULL
1998/Accepted	NULL
19	NULL
November	NULL
1998	NULL
Interleukin-8	NULL
(	NULL
IL-8	NULL
)	NULL
is	NULL
a	NULL
chemokine	NULL
that	NULL
belongs	NULL
to	NULL
the	NULL
«	NULL
-chemokine	NULL
or	NULL
CXC	NULL
subfamily	NULL
and	NULL
is	NULL
produced	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
human	NULL
cells	NULL
,	NULL
including	NULL
monocytes	NULL
and	NULL
polymorphonuclear	NULL
cells	NULL
(	NULL
PMN	NULL
)	NULL
.	NULL

IL-8	NULL
is	NULL
secreted	NULL
in	NULL
response	NULL
to	NULL
inflammatory	NULL
stimuli	NULL
,	NULL
notably	NULL
bacterial	NULL
products	NULL
such	NULL
as	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
but	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
these	NULL
agents	NULL
mediate	NULL
IL-8	NULL
induction	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
Mycoplasma	NULL
fermentans	NULL
lipid-associated	NULL
membrane	NULL
proteins	NULL
(	NULL
LAMPF	NULL
)	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
IL-8	NULL
by	NULL
THP-1	NULL
(	NULL
human	NULL
monocyte	NULL
)	NULL
cells	NULL
and	NULL
PMN	NULL
at	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
LPS	NULL
.	NULL

It	NULL
was	NULL
previously	NULL
demonstrated	NULL
that	NULL
stimulation	NULL
of	NULL
monocytic	NULL
cells	NULL
with	NULL
either	NULL
LPS	NULL
or	NULL
LAMPF	NULL
led	NULL
to	NULL
a	NULL
series	NULL
of	NULL
common	NULL
downstream	NULL
signaling	NULL
events	NULL
,	NULL
including	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
and	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascades	NULL
.	NULL

By	NULL
using	NULL
PD-98059	NULL
and	NULL
$	NULL
B203580	NULL
,	NULL
two	NULL
potent	NULL
and	NULL
selective	NULL
inhibitors	NULL
of	NULL
MEK1	NULL
(	NULL
a	NULL
kinase	NULL
upstream	NULL
of	NULL
ERK1/2	NULL
)	NULL
and	NULL
p38	NULL
,	NULL
respectively	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
both	NULL
ERK1/2	NULL
and	NULL
p38	NULL
cascades	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IL-8	NULL
by	NULL
monocytes	NULL
and	NULL
PMN	NULL
stimulated	NULL
with	NULL
bacterial	NULL
fractions	NULL
.	NULL

Chemokines	NULL
are	NULL
proinflammatory	NULL
cytokines	NULL
that	NULL
exhibit	NULL
chemotactic	NULL
and	NULL
stimulatory	NULL
activity	NULL
toward	NULL
blood	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Interleukin-8	NULL
(	NULL
IL-8	NULL
)	NULL
is	NULL
the	NULL
best-characterized	NULL
member	NULL
of	NULL
the	NULL
«	NULL
-chemokine	NULL
or	NULL
CXC	NULL
subfamily	NULL
(	NULL
2	NULL
,	NULL
32	NULL
)	NULL
.	NULL

IL-8	NULL
acts	NULL
primarily	NULL
on	NULL
polymorphonuclear	NULL
cells	NULL
(	NULL
PMN	NULL
)	NULL
but	NULL
also	NULL
has	NULL
potent	NULL
chemotactic	NULL
and	NULL
stimulatory	NULL
effects	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
basophils	NULL
,	NULL
or	NULL
eosino-phils	NULL
(	NULL
2	NULL
)	NULL
.	NULL

IL-8	NULL
is	NULL
released	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
monocytes/macrophages	NULL
,	NULL
neutrophils	NULL
,	NULL
T	NULL
lymphocytes	NULL
,	NULL
fibroblasts	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
epithelial	NULL
cells	NULL
upon	NULL
exposure	NULL
to	NULL
inflammatory	NULL
stimuli	NULL
such	NULL
as	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Besides	NULL
its	NULL
central	NULL
role	NULL
in	NULL
inflammation	NULL
process	NULL
,	NULL
IL-8	NULL
is	NULL
involved	NULL
in	NULL
other	NULL
biological	NULL
functions	NULL
such	NULL
as	NULL
angiogenesis	NULL
(	NULL
13	NULL
)	NULL
and	NULL
hematopoiesis	NULL
(	NULL
8	NULL
)	NULL
.	NULL

IL-8	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
various	NULL
diseases	NULL
,	NULL
including	NULL
rheumatoid	NULL
ar-thritis	NULL
,	NULL
psoriasis	NULL
,	NULL
asthma	NULL
,	NULL
pancreatitis	NULL
,	NULL
acute	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
,	NULL
and	NULL
sepsis	NULL
(	NULL
39	NULL
)	NULL
,	NULL
and	NULL
its	NULL
level	NULL
in	NULL
plasma	NULL
or	NULL
in	NULL
inflammatory	NULL
biological	NULL
fluids	NULL
is	NULL
often	NULL
correlated	NULL
with	NULL
the	NULL
severity	NULL
of	NULL
the	NULL
pathology	NULL
and/or	NULL
the	NULL
outcome	NULL
of	NULL
the	NULL
patients	NULL
(	NULL
19	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Mycoplasma	NULL
fermentans	NULL
is	NULL
a	NULL
potent	NULL
human	NULL
pathogen	NULL
that	NULL
is	NULL
suspected	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Unlike	NULL
all	NULL
the	NULL
other	NULL
bacteria	NULL
,	NULL
mycoplasmas	NULL
have	NULL
no	NULL
cell	NULL
wall	NULL
,	NULL
and	NULL
consequently	NULL
their	NULL
bilipid	NULL
membrane	NULL
is	NULL
the	NULL
only	NULL
structure	NULL
that	NULL
regulates	NULL
the	NULL
interaction	NULL
with	NULL
the	NULL
external	NULL
environment	NULL
.	NULL

One	NULL
of	NULL
the	NULL
responses	NULL
of	NULL
the	NULL
human	NULL
macrophages	NULL
to	NULL
gram-negative	NULL
bacterial	NULL
LPS	NULL
or	NULL
to	NULL
M.	NULL
fermentans	NULL
lipid-associated	NULL
membrane	NULL
proteins	NULL
(	NULL
LAMPf	NULL
)	NULL
is	NULL
the	NULL
production	NULL
of	NULL
proinflammatory	NULL
cyto-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Hoechst	NULL
Marion	NULL
Roussel	NULL
,	NULL
Anti-infectious	NULL
Group	NULL
,	NULL
102	NULL
route	NULL
de	NULL
Noisy	NULL
,	NULL
93235	NULL
Romainville	NULL
Cedex	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
33-1-49916199	NULL
.	NULL

Fax	NULL
:	NULL
33-1-49916380	NULL
.	NULL

E-mail	NULL
:	NULL
Georges.Rawadi	NULL
@	NULL
hmrag.com	NULL
.	NULL

688	NULL
kines	NULL
such	NULL
as	NULL
IL-1B	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
(	NULL
18	NULL
,	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
LPS	NULL
and	NULL
LAMPf	NULL
induce	NULL
the	NULL
secretion	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
are	NULL
not	NULL
completely	NULL
eluci-dated	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
signaling	NULL
pathways	NULL
involving	NULL
protein	NULL
kinases	NULL
clearly	NULL
participate	NULL
in	NULL
this	NULL
processus	NULL
(	NULL
16	NULL
,	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Whereas	NULL
LPS	NULL
from	NULL
distinct	NULL
gram-negative	NULL
bacteria	NULL
including	NULL
Escherichia	NULL
coli	NULL
,	NULL
Neisseria	NULL
meningitidis	NULL
,	NULL
and	NULL
Klebsiella	NULL
pneumoniae	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
potent	NULL
inducers	NULL
of	NULL
IL-8	NULL
production	NULL
in	NULL
monocytic	NULL
cells	NULL
and	NULL
PMN	NULL
(	NULL
9	NULL
)	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
M.	NULL
fermentans	NULL
lipoproteins	NULL
to	NULL
induce	NULL
IL-8	NULL
secretion	NULL
by	NULL
these	NULL
cells	NULL
has	NULL
not	NULL
been	NULL
addressed	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
tested	NULL
and	NULL
compared	NULL
the	NULL
abilities	NULL
of	NULL
LAMPf	NULL
and	NULL
£	NULL
.	NULL

coli	NULL
(	NULL
055	NULL
:	NULL
B5	NULL
)	NULL
LPS	NULL
to	NULL
induce	NULL
IL-8	NULL
production	NULL
by	NULL
the	NULL
human	NULL
promyelomonocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
,	NULL
human	NULL
monocytes/macrophages	NULL
,	NULL
and	NULL
PMN	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
evaluated	NULL
the	NULL
role	NULL
that	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
pathways	NULL
play	NULL
in	NULL
the	NULL
IL-8	NULL
production	NULL
induced	NULL
by	NULL
these	NULL
bacterial	NULL
products	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

PD-98059	NULL
and	NULL
caffeic	NULL
acid	NULL
phenetyl	NULL
ester	NULL
(	NULL
CAPE	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Biomol	NULL
Research	NULL
Laboratories	NULL
(	NULL
Philadelphia	NULL
,	NULL
Pa.	NULL
)	NULL
$	NULL
B203580	NULL
and	NULL
herbimycin	NULL
A	NULL
were	NULL
from	NULL
Calbiochem	NULL
(	NULL
Nottingham	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

£	NULL
.	NULL

coli	NULL
LPS	NULL
(	NULL
O55	NULL
:	NULL
B5	NULL
)	NULL
and	NULL
polymyxin	NULL
B	NULL
were	NULL
from	NULL
Sigma	NULL
L'Isle	NULL
D'Abeauhesnes	NULL
,	NULL
France	NULL
)	NULL
.	NULL

MY4	NULL
,	NULL
an	NULL
anti-human	NULL
CD14	NULL
monoclonal	NULL
antibody	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Coulter	NULL
Diagnostics	NULL
(	NULL
Hialeah	NULL
,	NULL
Fla.	NULL
)	NULL
.	NULL

Mycoplasma	NULL
culture	NULL
and	NULL
LAMPf	NULL
preparation	NULL
.	NULL

M.	NULL
fermentans	NULL
PG18	NULL
was	NULL
cultivated	NULL
in	NULL
medium	NULL
containing	NULL
20	NULL
%	NULL
horse	NULL
serum	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
,	NULL
10	NULL
%	NULL
freshly	NULL
prepared	NULL
yeast	NULL
extract	NULL
,	NULL
1	NULL
%	NULL
glucose	NULL
,	NULL
and	NULL
1,000	NULL
U	NULL
of	NULL
penicillin	NULL
G	NULL
per	NULL
ml	NULL
.	NULL

Mycoplasma	NULL
cultures	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
then	NULL
quantified	NULL
as	NULL
described	NULL
by	NULL
Rodwell	NULL
and	NULL
Whitcomb	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
expressed	NULL
as	NULL
CFU	NULL
per	NULL
milliliter	NULL
.	NULL

LAMPE	NULL
preparations	NULL
were	NULL
made	NULL
by	NULL
hydrophilic/hydrophobic	NULL
fractionation	NULL
using	NULL
the	NULL
TX-114	NULL
partitioning	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
means	NULL
of	NULL
micro-BCA	NULL
assay	NULL
(	NULL
bicinchoninic	NULL
acid	NULL
)	NULL
(	NULL
Pierce	NULL
,	NULL
voL	NULL
.	NULL

67	NULL
,	NULL
1999	NULL
Rockford	NULL
,	NULL
IIL	NULL
)	NULL
.	NULL

The	NULL
endotoxin	NULL
level	NULL
of	NULL
the	NULL
preparations	NULL
was	NULL
<	NULL
60	NULL
pg/ml	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
Haemachem	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

.	NULL

THP-1	NULL
cell	NULL
line	NULL
culture	NULL
and	NULL
stimulation	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
was	NULL
cultured	NULL
(	NULL
37°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
)	NULL
in	NULL
RPMI	NULL
1640	NULL
culture	NULL
medium	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Cell	NULL
line	NULL
were	NULL
tested	NULL
every	NULL
2	NULL
weeks	NULL
by	NULL
a	NULL
PCR-based	NULL
detection	NULL
assay	NULL
for	NULL
mycoplasma	NULL
contamination	NULL
(	NULL
26	NULL
)	NULL
.	NULL

For	NULL
stimulation	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
a	NULL
density	NULL
of	NULL
105/ml	NULL
and	NULL
then	NULL
incubated	NULL
overnight	NULL
.	NULL

For	NULL
cytokine	NULL
production	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LAMPF	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

or	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
18	NULL
h.	NULL
Isolation	NULL
of	NULL
human	NULL
monocytes	NULL
and	NULL
PMN	NULL
.	NULL

Fresh	NULL
human	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
healthy	NULL
donors	NULL
(	NULL
Etablissement	NULL
de	NULL
Transfusion	NULL
Sanguine	NULL
de	NULL
Assistance	NULL
Publique	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
and	NULL
drawn	NULL
on	NULL
citrate-phosphate-dextrose	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
selected	NULL
by	NULL
adherence	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
1:2-diluted	NULL
blood	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Glutamax	NULL
;	NULL
Life	NULL
Technologies	NULL
,	NULL
Paisley	NULL
,	NULL
Scotland	NULL
)	NULL
was	NULL
layered	NULL
on	NULL
Ficoll-Hypaque	NULL
(	NULL
MSL	NULL
;	NULL
Eurobio	NULL
,	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
ratio	NULL
was	NULL
2	NULL
volumes	NULL
of	NULL
blood	NULL
to	NULL
1	NULL
volume	NULL
of	NULL
MSL	NULL
.	NULL

After	NULL
centrifugation	NULL
for	NULL
20	NULL
min	NULL
at	NULL
15°C	NULL
and	NULL
600	NULL
x	NULL
g	NULL
,	NULL
PBMC	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
then	NULL
counted	NULL
in	NULL
0.1	NULL
%	NULL
eosin	NULL
.	NULL

PMN	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
volumes	NULL
of	NULL
blood	NULL
was	NULL
mixed	NULL
with	NULL
2	NULL
volumes	NULL
of	NULL
glucose	NULL
dextran	NULL
(	NULL
3	NULL
%	NULL
glucose	NULL
,	NULL
3	NULL
%	NULL
dextran	NULL
T250	NULL
;	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
,	NULL
and	NULL
the	NULL
leukocytes	NULL
were	NULL
recovered	NULL
following	NULL
a	NULL
40-min	NULL
sedimentation	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
leukocytes	NULL
were	NULL
then	NULL
diluted	NULL
1:2	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
and	NULL
layered	NULL
on	NULL
Ficoll-Hypaque	NULL
.	NULL

After	NULL
centrifugation	NULL
for	NULL
20	NULL
min	NULL
at	NULL
15°C	NULL
and	NULL
600	NULL
x	NULL
g	NULL
,	NULL
the	NULL
cell	NULL
pellet	NULL
was	NULL
washed	NULL
and	NULL
centrifuged	NULL
once	NULL
for	NULL
5	NULL
min	NULL
at	NULL
300	NULL
x	NULL
g.	NULL
Contaminating	NULL
erythrocytes	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
the	NULL
viability	NULL
of	NULL
PMN	NULL
was	NULL
assessed	NULL
by	NULL
counting	NULL
the	NULL
cells	NULL
in	NULL
0.1	NULL
%	NULL
eosin	NULL
.	NULL

Monocytes	NULL
and	NULL
PMN	NULL
culture	NULL
and	NULL
stimulation	NULL
.	NULL

PBMC	NULL
were	NULL
adjusted	NULL
to	NULL
6	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
(	NULL
penicillin	NULL
[	NULL
100	NULL
TU/m	NULL
!	NULL
]	NULL

and	NULL
streptomycin	NULL
[	NULL
100	NULL
pg/ml	NULL
)	NULL
;	NULL
0.5-ml	NULL
aliquots	NULL
of	NULL
PBMC	NULL
suspension	NULL
per	NULL
well	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
incubator	NULL
in	NULL
24-well	NULL
multidish	NULL
plates	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
nonadherent	NULL
cells	NULL
were	NULL
then	NULL
discarded	NULL
,	NULL
and	NULL
the	NULL
remaining	NULL
adherent	NULL
cells	NULL
were	NULL
washed	NULL
extensively	NULL
;	NULL
0.5	NULL
ml	NULL
of	NULL
fresh	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
and	NULL
0.2	NULL
%	NULL
heat-inac-tivated	NULL
normal	NULL
human	NULL
serum	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
monocytes	NULL
were	NULL
further	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

At	NULL
24	NULL
h	NULL
,	NULL
the	NULL
adherent	NULL
monocytes/macrophages	NULL
were	NULL
washed	NULL
again	NULL
and	NULL
cultured	NULL
for	NULL
another	NULL
24-h	NULL
period	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
fresh	NULL
medium	NULL
.	NULL

At	NULL
48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
stimulating	NULL
agents	NULL
.	NULL

PMN	NULL
were	NULL
adjusted	NULL
to	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
and	NULL
5	NULL
%	NULL
normal	NULL
human	NULL
serum	NULL
.	NULL

Then	NULL
0.5-ml	NULL
aliquots	NULL
of	NULL
PMN	NULL
suspension	NULL
per	NULL
well	NULL
were	NULL
incubated	NULL
in	NULL
24-well	NULL
multidish	NULL
plates	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
incubator	NULL
for	NULL
24	NULL
h	NULL
at	NULL
37°C	NULL
with	NULL
stimulating	NULL
agents	NULL
.	NULL

Dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
solvent	NULL
control	NULL
.	NULL

RNA	NULL
purification	NULL
and	NULL
NPA	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
described	NULL
above	NULL
at	NULL
various	NULL
times	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
10	NULL
``	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
total	NULL
RNA	NULL
isolation	NULL
kit	NULL
from	NULL
Bioprobe	NULL
(	NULL
Montreuil	NULL
,	NULL
France	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Nuclease	NULL
protection	NULL
assay	NULL
(	NULL
NPA	NULL
)	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
IL-8	NULL
transcript	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Multi-NPA	NULL
kit	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
Tex	NULL
.	NULL
)	NULL

as	NULL
instructed	NULL
by	NULL
the	NULL
manufacturer	NULL
,	NULL
using	NULL
an	NULL
IL-8	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
a	NULL
28S	NULL
rRNA	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Ambion	NULL
)	NULL
for	NULL
standardization	NULL
.	NULL

NPA	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
a	NULL
PhosphorImager	NULL
screen	NULL
,	NULL
and	NULL
the	NULL
signals	NULL
were	NULL
quantified	NULL
with	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

All	NULL
determinations	NULL
were	NULL
repeated	NULL
three	NULL
to	NULL
four	NULL
times	NULL
;	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
(	NULL
SEM	NULL
)	NULL
.	NULL

Plasmids	NULL
,	NULL
cell	NULL
transfection	NULL
,	NULL
activation	NULL
,	NULL
and	NULL
assay	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B-driven	NULL
and	NULL
AP-1-driven	NULL
(	NULL
3	NULL
)	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
were	NULL
kindly	NULL
provide	NULL
by	NULL
O.	NULL
Acuto	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
by	NULL
Stacey	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
overnight	NULL
in	NULL
growth	NULL
medium	NULL
and	NULL
then	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
or	NULL
LPS	NULL
for	NULL
6	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
harvested	NULL
,	NULL
the	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
micro-BCA	NULL
assay	NULL
(	NULL
Pierce	NULL
)	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Specific	NULL
luciferase	NULL
activity	NULL
,	NULL
determined	NULL
in	NULL
duplicate	NULL
samples	NULL
by	NULL
using	NULL
an	NULL
automated	NULL
luminometer	NULL
(	NULL
Lumat	NULL
LB	NULL
9501	NULL
;	NULL
EG1G	NULL
Berthod	NULL
,	NULL
Wilbad	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
was	NULL
determined	NULL
in	NULL
arbitrary	NULL
units	NULL
after	NULL
normalization	NULL
to	NULL
the	NULL
protein	NULL
content	NULL
.	NULL

Luciferase	NULL
fold	NULL
induction	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
specific	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
stimulated	NULL
cells	NULL
to	NULL
that	NULL
in	NULL
the	NULL
unstimulated	NULL
cells	NULL
.	NULL

Cytokine	NULL
ELISA	NULL
.	NULL

IL-8	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
,	NULL
using	NULL
a	NULL
monoclonal	NULL
anti-human	NULL
antibody	NULL
obtained	NULL
by	NULL
J.	NULL
C.	NULL
Mazié	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
and	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-IL-8	NULL
antibody	NULL
graciously	NULL
provided	NULL
by	NULL
N.	NULL
Vita	NULL
(	NULL
Sanofi	NULL
Recherche	NULL
,	NULL
Labége	NULL
,	NULL
France	NULL
)	NULL
.	NULL

RESULTS	NULL
LAMPF	NULL
induces	NULL
IL-8	NULL
secretion	NULL
by	NULL
THP-1	NULL
cells	NULL
,	NULL
human	NULL
monocytes/macrophages	NULL
,	NULL
and	NULL
human	NULL
PMN	NULL
.	NULL

Mycoplasma	NULL
membrane	NULL
lipoproteins	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
strongly	NULL
stimulate	NULL
the	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
by	NULL
human	NULL
monocytic	NULL
cells	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
;	NULL
however	NULL
,	NULL
their	NULL
ability	NULL
to	NULL
induce	NULL
IL-8	NULL
secretion	NULL
by	NULL
INVOLVEMENT	NULL
OF	NULL
MAPK	NULL
PATHWAYS	NULL
IN	NULL
IL-8	NULL
PRODUCTION	NULL
-	NULL
689	NULL
>	NULL
w	NULL
100	NULL
LAMPE	NULL
_	NULL
0	NULL
2h	NULL
4h	NULL
6h	NULL
Sh	NULL
g	NULL
10	NULL
E	NULL
3	NULL
9	NULL
P	NULL
a	NULL
``	NULL
of	NULL
0,01	NULL
C	NULL
WWW	NULL
“	NULL
I	NULL
sumone	NULL
Perentage	NULL
of	NULL
IL-8	NULL
production	NULL
normalized	NULL
to	NULL
control	NULL
levels	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
LAMP	NULL
Cugat	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

IL-8	NULL
production	NULL
by	NULL
human	NULL
THP-1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LAMPf	NULL
and	NULL
LPS	NULL
.	NULL

(	NULL
A	NULL
)	NULL
THP-1	NULL
cells	NULL
(	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
not	NULL
stimulated	NULL
(	NULL
control	NULL
[	NULL
CTRL	NULL
]	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
either	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
or	NULL
LAMPF	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

IL-8	NULL
production	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
18	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
distinct	NULL
assays	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Multi-NPA	NULL
using	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
IL-8	NULL
and	NULL
28S	NULL
rRNA	NULL
(	NULL
for	NULL
standardization	NULL
)	NULL
.	NULL

RNAs	NULL
were	NULL
prepared	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
0	NULL
)	NULL
and	NULL
THP-1	NULL
cells	NULL
induced	NULL
with	NULL
LAMPf	NULL
(	NULL
1	NULL
g/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
time	NULL
and	NULL
subjected	NULL
to	NULL
multi-NPA	NULL
analysis	NULL
.	NULL

Multi-NPA	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
a	NULL
PhosphorImager	NULL
screen	NULL
for	NULL
2	NULL
to	NULL
4	NULL
h	NULL
;	NULL
the	NULL
gel	NULL
shown	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

IL-8	NULL
and	NULL
288	NULL
rRNA	NULL
oligonucleotide	NULL
probes	NULL
protect	NULL
24	NULL
and	NULL
35	NULL
bases	NULL
of	NULL
the	NULL
IL-8	NULL
and	NULL
288	NULL
rRNA	NULL
transcripts	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
IL-8	NULL
signal	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
quantitatively	NULL
assessed	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
28	NULL
$	NULL
rRNA	NULL
signal	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Effect	NULL
of	NULL
anti-CD14	NULL
antibody	NULL
treatments	NULL
on	NULL
LAMPF-induced	NULL
IL-8	NULL
secretion	NULL
.	NULL

Human	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
anti-human	NULL
CD14	NULL
monoclonal	NULL
antibody	NULL
MY4	NULL
at	NULL
5	NULL
pg/ml	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
either	NULL
LAMPf	NULL
(	NULL
1	NULL
g/m	NULL
!	NULL
)	NULL

or	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
.	NULL

An	NULL
irrelevant	NULL
antibody	NULL
(	NULL
NS	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

IL-8	NULL
secretion	NULL
was	NULL
determined	NULL
after	NULL
18	NULL
h	NULL
of	NULL
culture	NULL
and	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
secretion	NULL
normalized	NULL
to	NULL
stimulated	NULL
cells	NULL
that	NULL
received	NULL
no	NULL
antibody	NULL
treatment	NULL
.	NULL

Mean	NULL
values	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

these	NULL
cells	NULL
has	NULL
not	NULL
been	NULL
previously	NULL
addressed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
Triton	NULL
X-114	NULL
fractionated	NULL
LAMPf	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
induced	NULL
the	NULL
release	NULL
of	NULL
a	NULL
considerable	NULL
amount	NULL
of	NULL
IL-8	NULL
by	NULL
THP	NULL
cells	NULL
after	NULL
18	NULL
h	NULL
of	NULL
stimulation	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
the	NULL
level	NULL
of	NULL
IL-8	NULL
in	NULL
THP-1	NULL
cells	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

We	NULL
further	NULL
investigated	NULL
the	NULL
expression	NULL
of	NULL
IL-8	NULL
mRNA	NULL
in	NULL
THP-1	NULL
cells	NULL
challenged	NULL
with	NULL
LAMPf	NULL
by	NULL
multi-NPA	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
LAMPf	NULL
induced	NULL
the	NULL
synthesis	NULL
of	NULL
IL-8	NULL
mRNA	NULL
2	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
and	NULL
the	NULL
mRNA	NULL
level	NULL
increased	NULL
continuously	NULL
up	NULL
to	NULL
8	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
incubation	NULL
time	NULL
was	NULL
normalized	NULL
by	NULL
probing	NULL
for	NULL
28S	NULL
rRNA	NULL
.	NULL

Quantitative	NULL
analysis	NULL
demonstrated	NULL
that	NULL
at	NULL
8	NULL
h	NULL
poststimulation	NULL
,	NULL
the	NULL
IL-8	NULL
signal	NULL
in	NULL
LAMPf-stimu-lated	NULL
cells	NULL
,	NULL
after	NULL
correction	NULL
by	NULL
the	NULL
288	NULL
rRNA	NULL
signal	NULL
,	NULL
was	NULL
1,033	NULL
%	NULL
of	NULL
the	NULL
IL-8	NULL
signal	NULL
in	NULL
control	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

690	NULL
MARIE	NULL
ET	NULL
AL	NULL
.	NULL

1000	NULL
fg	NULL
monocytes	NULL
D	NULL
PMN	NULL
100	NULL
IL-8	NULL
production	NULL
.	NULL

(	NULL
ng/ml	NULL
)	NULL
3	NULL
0,41	NULL
¥	NULL
&	NULL
&	NULL
£	NULL
&	NULL
S	NULL
L	NULL
4	NULL
Up	NULL
,	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

IL-8	NULL
production	NULL
by	NULL
human	NULL
monocytes	NULL
and	NULL
PMN	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
or	NULL
LPS	NULL
.	NULL

PBMC	NULL
(	NULL
6	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
and	NULL
PMN	NULL
(	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
unstimulated	NULL
(	NULL
control	NULL
[	NULL
CTRL	NULL
]	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
either	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
or	NULL
LAMPF	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

IL-8	NULL
production	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
18	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
and	NULL
five	NULL
distinct	NULL
assays	NULL
for	NULL
monocytes	NULL
and	NULL
PMN	NULL
,	NULL
respectively	NULL
.	NULL

Treatment	NULL
of	NULL
LAMPf	NULL
with	NULL
polymyxin	NULL
B	NULL
(	NULL
1,000	NULL
U/ml	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
IL-8	NULL
induction	NULL
mediated	NULL
by	NULL
LAMPf	NULL
,	NULL
whereas	NULL
polymyxin	NULL
B	NULL
completely	NULL
blocked	NULL
LPS-induced	NULL
IL-8	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
anti-CD14	NULL
monoclonal	NULL
antibody	NULL
MY4	NULL
,	NULL
which	NULL
significantly	NULL
reduced	NULL
LPS-induced	NULL
IL-8	NULL
production	NULL
by	NULL
THP	NULL
-1	NULL
cells	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-8	NULL
secretion	NULL
by	NULL
the	NULL
same	NULL
cells	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

We	NULL
also	NULL
assessed	NULL
the	NULL
production	NULL
of	NULL
IL-8	NULL
by	NULL
human	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
challenged	NULL
with	NULL
LAMPf	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
LAMPf	NULL
induced	NULL
IL-8	NULL
secretion	NULL
by	NULL
human	NULL
monocytes/macrophages	NULL
after	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
.	NULL

Culture	NULL
conditions	NULL
and	NULL
stimulation	NULL
of	NULL
human	NULL
monocytes/macrophages	NULL
had	NULL
to	NULL
be	NULL
adjusted	NULL
in	NULL
order	NULL
to	NULL
reduce	NULL
the	NULL
amount	NULL
of	NULL
spontaneous	NULL
IL-8	NULL
release	NULL
by	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
with	NULL
the	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
IL-8	NULL
secreted	NULL
by	NULL
unstimulated	NULL
THP	NULL
-1	NULL
cells	NULL
,	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
this	NULL
chemokine	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
24-h-cultured	NULL
human	NULL
monocytes/macrophages	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
stimulus	NULL
.	NULL

However	NULL
,	NULL
spontaneous	NULL
IL-8	NULL
release	NULL
was	NULL
dramatically	NULL
reduced	NULL
(	NULL
80	NULL
%	NULL
reduction	NULL
)	NULL
when	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
and	NULL
washed	NULL
each	NULL
24	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
these	NULL
conditions	NULL
,	NULL
LAMPf	NULL
stimulation	NULL
induced	NULL
a	NULL
100-fold	NULL
increase	NULL
in	NULL
IL-8	NULL
secretion	NULL
in	NULL
comparison	NULL
to	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
PMN	NULL
constitute	NULL
excellent	NULL
producers	NULL
of	NULL
IL-8	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
mycoplasma	NULL
lipoproteins	NULL
on	NULL
the	NULL
secretion	NULL
of	NULL
this	NULL
chemokine	NULL
.	NULL

LAMPf	NULL
increased	NULL
strongly	NULL
(	NULL
100-fold	NULL
)	NULL
the	NULL
release	NULL
of	NULL
IL-8	NULL
by	NULL
PMN	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
induction	NULL
of	NULL
IL-8	NULL
secretion	NULL
by	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
£	NULL
.	NULL

coli	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
or	NULL
LAMPf	NULL
were	NULL
fully	NULL
comparable	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
is	NULL
required	NULL
for	NULL
IL-8	NULL
induction	NULL
by	NULL
LAMPf	NULL
and	NULL
LPS	NULL
.	NULL

Stimulation	NULL
of	NULL
monocytic	NULL
cells	NULL
with	NULL
either	NULL
LAMPf	NULL
or	NULL
LPS	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
residues	NULL
of	NULL
a	NULL
series	NULL
of	NULL
unidentified	NULL
proteins	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
in	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
or	NULL
LAMPf	NULL
seems	NULL
to	NULL
be	NULL
maximal	NULL
at	NULL
10	NULL
or	NULL
20	NULL
min	NULL
,	NULL
respectively	NULL
,	NULL
after	NULL
stimulation	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
constitutes	NULL
a	NULL
crucial	NULL
event	NULL
in	NULL
the	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
IL-1	NULL
B	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
IL-6	NULL
production	NULL
by	NULL
monocytes/macrophages	NULL
stimulated	NULL
with	NULL
either	NULL
LPS	NULL
or	NULL
LAMPf	NULL
(	NULL
12	NULL
,	NULL
28	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
involvement	NULL
of	NULL
PTK	NULL
in	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
,	NULL
we	NULL
used	NULL
the	NULL
specific	NULL
PTK	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
.	NULL

Prior	NULL
to	NULL
stimulation	NULL
,	NULL
human	NULL
monocytes/macrophages	NULL
or	NULL
PMN	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
herbimycin	NULL
A	NULL
at	NULL
10	NULL
wM	NULL
(	NULL
a	NULL
con	NULL
INFECT	NULL
.	NULL

ImMUN	NULL
.	NULL

centration	NULL
that	NULL
does	NULL
not	NULL
affect	NULL
cell	NULL
viability	NULL
)	NULL
,	NULL
and	NULL
IL-8	NULL
production	NULL
was	NULL
monitored	NULL
by	NULL
specific	NULL
ELISA	NULL
after	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
herbimycin	NULL
A	NULL
completely	NULL
inhibited	NULL
IL-8	NULL
production	NULL
in	NULL
response	NULL
to	NULL
LAMPf	NULL
.	NULL

Herbimycin	NULL
A	NULL
at	NULL
10	NULL
mM	NULL
also	NULL
completely	NULL
blocked	NULL
IL-8	NULL
production	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

These	NULL
data	NULL
clearly	NULL
underscore	NULL
the	NULL
involvement	NULL
of	NULL
PTK	NULL
in	NULL
the	NULL
signaling	NULL
cascades	NULL
leading	NULL
to	NULL
IL-8	NULL
production	NULL
by	NULL
monocytes/	NULL
macrophages	NULL
and	NULL
PMN	NULL
in	NULL
response	NULL
to	NULL
both	NULL
LAMPf	NULL
and	NULL
bacterial	NULL
LPS	NULL
.	NULL

MAPK	NULL
signaling	NULL
is	NULL
a	NULL
key	NULL
event	NULL
in	NULL
IL-8	NULL
induction	NULL
by	NULL
LAMPf	NULL
and	NULL
LPS	NULL
.	NULL

MAPKs	NULL
are	NULL
a	NULL
group	NULL
of	NULL
serine/threonine-specific	NULL
,	NULL
proline-directed	NULL
protein	NULL
kinases	NULL
which	NULL
are	NULL
activated	NULL
by	NULL
various	NULL
extracellular	NULL
stimuli	NULL
.	NULL

Well-characterized	NULL
MAPK	NULL
pathways	NULL
include	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
1	NULL
and	NULL
2	NULL
(	NULL
ERK1/2	NULL
)	NULL
,	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
/stress-activated	NULL
protein	NULL
ki-nases	NULL
,	NULL
and	NULL
p38/RK/Mpk2	NULL
(	NULL
40	NULL
)	NULL
.	NULL

LPS	NULL
and	NULL
LAMPf	NULL
are	NULL
capable	NULL
of	NULL
activating	NULL
ERK1/2	NULL
and	NULL
p38	NULL
pathways	NULL
in	NULL
monocytes/macrophages	NULL
,	NULL
although	NULL
with	NULL
different	NULL
kinetics	NULL
of	NULL
activation	NULL
(	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
involvement	NULL
of	NULL
ERK1/2	NULL
and	NULL
p38	NULL
pathways	NULL
in	NULL
LAMP	NULL
{	NULL
-	NULL
and	NULL
LPS-induced	NULL
IL-8	NULL
production	NULL
in	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
,	NULL
we	NULL
used	NULL
two	NULL
specific	NULL
inhibitors	NULL
:	NULL
PD-98059	NULL
,	NULL
which	NULL
targets	NULL
the	NULL
upstream	NULL
effector	NULL
of	NULL
ERK1/2	NULL
MEKI1	NULL
(	NULL
1	NULL
,	NULL
11	NULL
)	NULL
;	NULL
and	NULL
$	NULL
B203580	NULL
,	NULL
which	NULL
inhibits	NULL
p38	NULL
kinase	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
$	NULL
B203580	NULL
selectively	NULL
inhibited	NULL
the	NULL
LAMPf-mediated	NULL
activation	NULL
of	NULL
p38	NULL
without	NULL
significantly	NULL
affecting	NULL
the	NULL
stimulation	NULL
of	NULL
ERK1/2	NULL
or	NULL
JNK	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Human	NULL
monocytes/macrophages	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
S	NULL
$	NULL
B203580	NULL
before	NULL
stimulation	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
p38	NULL
pathway	NULL
inhibitor	NULL
significantly	NULL
reduced	NULL
IL-8	NULL
production	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
in	NULL
response	NULL
to	NULL
LAMPf	NULL
.	NULL

Furthermore	NULL
,	NULL
$	NULL
B203580	NULL
also	NULL
inhibited	NULL
IL-8	NULL
production	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
treatment	NULL
of	NULL
PMN	NULL
with	NULL
$	NULL
B203580	NULL
almost	NULL
completely	NULL
blocked	NULL
IL-8	NULL
production	NULL
induced	NULL
by	NULL
both	NULL
agents	NULL
.	NULL

No	NULL
cell	NULL
toxicity	NULL
was	NULL
observed	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
$	NULL
B203580	NULL
at	NULL
the	NULL
highest	NULL
used	NULL
concentration	NULL
(	NULL
30	NULL
M	NULL
)	NULL
.	NULL

These	NULL
data	NULL
underscore	NULL
the	NULL
involvement	NULL
of	NULL
p38	NULL
pathway	NULL
in	NULL
signaling	NULL
for	NULL
IL-8	NULL
production	NULL
in	NULL
both	NULL
human	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
.	NULL

100	NULL
maz	NULL
:	NULL
I	NULL
Monocytes	NULL
[	NULL
]	NULL
run	NULL
z	NULL
80	NULL
-	NULL
|-E	NULL
a	NULL
2	NULL
A	NULL
2	NULL
&	NULL
60	NULL
7	NULL
-I	NULL
%	NULL
2	NULL
3	NULL
8	NULL
40	NULL
-	NULL
--	NULL
3	NULL
3	NULL
5	NULL
&	NULL
20	NULL
-	NULL
|	NULL
--	NULL
Lrg	NULL
&	NULL
&	NULL
5	NULL
bd	NULL
Herbimycin	NULL
A	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
PTK	NULL
blockade	NULL
on	NULL
IL-8	NULL
production	NULL
.	NULL

Monocytes	NULL
and	NULL
PMN	NULL
were	NULL
incubated	NULL
with	NULL
herbimycin	NULL
A	NULL
(	NULL
10	NULL
wM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
or	NULL
LAMPF	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
stimulation	NULL
.	NULL

DMSO	NULL
(	NULL
1	NULL
%	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
solvent	NULL
control	NULL
.	NULL

The	NULL
IL-8	NULL
level	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
18	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
normalized	NULL
to	NULL
cells	NULL
that	NULL
received	NULL
no	NULL
treatment	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
and	NULL
three	NULL
distinct	NULL
experiments	NULL
for	NULL
monocytes	NULL
and	NULL
PMN	NULL
,	NULL
respectively	NULL
.	NULL

voL	NULL
.	NULL

67	NULL
,	NULL
1999	NULL
>	NULL
100	NULL
N	NULL
monocytes	NULL
PMN	NULL
80	NULL
%	NULL
OF	NULL
CONTROL	NULL
CELLS	NULL
RESPONSE	NULL
o	NULL
¢	NULL
[	NULL
4	NULL
g	NULL
¢	NULL
g	NULL
4	NULL
6	NULL
$	NULL
B	NULL
o	NULL
$	NULL
$	NULL
SB-203580	NULL
PD-98059	NULL
B	NULL
100	NULL
N	NULL
monocytes	NULL
E	NULL
PMN	NULL
80	NULL
%	NULL
OF	NULL
CONTROL	NULL
CELLS	NULL
RESPONSE	NULL
SB-203580	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
ERK1/2	NULL
and	NULL
p38	NULL
pathway-specific	NULL
inhibitors	NULL
on	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
monocytes	NULL
and	NULL
PMN	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
either	NULL
PD-98059	NULL
(	NULL
MEK1	NULL
inhibitor	NULL
)	NULL
or	NULL
$	NULL
B203580	NULL
(	NULL
p38	NULL
inhibitor	NULL
)	NULL
at	NULL
different	NULL
concentrations	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
LAMPF	NULL
(	NULL
1	NULL
g/ml	NULL
)	NULL
(	NULL
A	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

DMSO	NULL
(	NULL
1	NULL
%	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
solvent	NULL
control	NULL
.	NULL

The	NULL
IL-8	NULL
level	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
18	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
normalized	NULL
to	NULL
cells	NULL
that	NULL
received	NULL
no	NULL
treatment	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

Results	NULL
are	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
and	NULL
three	NULL
separate	NULL
experiments	NULL
for	NULL
monocytes	NULL
and	NULL
PMN	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
MEK-1	NULL
inhibitor	NULL
,	NULL
PD-98059	NULL
,	NULL
selectively	NULL
inhibited	NULL
the	NULL
or	NULL
LPS-mediated	NULL
activation	NULL
of	NULL
ERK1/2	NULL
in	NULL
macrophages	NULL
without	NULL
significantly	NULL
affecting	NULL
the	NULL
stimulation	NULL
of	NULL
p38	NULL
or	NULL
JNK	NULL
,	NULL
and	NULL
no	NULL
cell	NULL
toxicity	NULL
was	NULL
observed	NULL
with	NULL
this	NULL
compound	NULL
up	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
30	NULL
uM	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
human	NULL
monocytes/macrophages	NULL
with	NULL
PD-98059	NULL
significantly	NULL
decreased	NULL
IL-8	NULL
production	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PD-98059	NULL
treatment	NULL
strongly	NULL
reduced	NULL
IL-8	NULL
production	NULL
in	NULL
human	NULL
monocytes/macrophages	NULL
challenged	NULL
with	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
MEK-1	NULL
in	NULL
PMN	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
IL-8	NULL
production	NULL
after	NULL
both	NULL
LAMPf	NULL
and	NULL
LPS	NULL
challenge	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
PMN	NULL
were	NULL
found	NULL
overall	NULL
to	NULL
be	NULL
more	NULL
sensitive	NULL
than	NULL
monocytes/macrophages	NULL
to	NULL
treatment	NULL
with	NULL
either	NULL
PD-98059	NULL
or	NULL
$	NULL
B203580	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
data	NULL
clearly	NULL
indicate	NULL
the	NULL
importance	NULL
of	NULL
MAPK	NULL
pathways	NULL
in	NULL
the	NULL
signaling	NULL
leading	NULL
to	NULL
IL-8	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
both	NULL
LAMPf	NULL
and	NULL
E.	NULL
coli	NULL
LPS	NULL
.	NULL

INVOLVEMENT	NULL
OF	NULL
MAPK	NULL
PATHWAYS	NULL
IN	NULL
IL-8	NULL
PRODUCTION	NULL
-	NULL
691	NULL
Involvement	NULL
of	NULL
NF-KB	NULL
in	NULL
IL-8	NULL
production	NULL
in	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
inflammation	NULL
response	NULL
(	NULL
43	NULL
)	NULL
.	NULL

It	NULL
is	NULL
well	NULL
documented	NULL
that	NULL
LPS	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
monocytes	NULL
and	NULL
regulates	NULL
cytokine	NULL
expression	NULL
(	NULL
10	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
LAMPf	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
monocytic	NULL
cells	NULL
(	NULL
292	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
addressed	NULL
the	NULL
involvement	NULL
of	NULL
NF-kB	NULL
in	NULL
IL-8	NULL
production	NULL
by	NULL
LAMP	NULL
{	NULL
-	NULL
and	NULL
LPS-stimulated	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
IL-8	NULL
production	NULL
induced	NULL
by	NULL
these	NULL
bacterial	NULL
stimuli	NULL
,	NULL
we	NULL
used	NULL
the	NULL
recently	NULL
reported	NULL
specific	NULL
NF-kB	NULL
inhibitor	NULL
CAPE	NULL
(	NULL
25	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
LAMPf	NULL
induced	NULL
a	NULL
threefold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
in	NULL
THP-1	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
NF-xB-driven	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
LAMPf	NULL
was	NULL
capable	NULL
of	NULL
inducing	NULL
AP-1	NULL
transactivation	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
measuring	NULL
luciferase	NULL
activity	NULL
in	NULL
THP-1	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
AP-1-driven	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
and	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
THP	NULL
transfected	NULL
cells	NULL
with	NULL
CAPE	NULL
(	NULL
10	NULL
to	NULL
100	NULL
wM	NULL
)	NULL
inhibited	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
NF-	NULL
«	NULL
B-mediated	NULL
luciferase	NULL
activation	NULL
induced	NULL
by	NULL
LAMPf	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

No	NULL
cell	NULL
toxicity	NULL
was	NULL
observed	NULL
with	NULL
CAPE	NULL
at	NULL
100	NULL
mM	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
blue	NULL
trypan	NULL
uptake	NULL
;	NULL
at	NULL
higher	NULL
concentration	NULL
,	NULL
however	NULL
,	NULL
this	NULL
inhibitor	NULL
induced	NULL
cell	NULL
death	NULL
(	NULL
>	NULL
50	NULL
%	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
at	NULL
100	NULL
wM	NULL
CAPE	NULL
completely	NULL
blocked	NULL
NF-	NULL
«	NULL
kB-dependent	NULL
luciferase	NULL
activation	NULL
but	NULL
affect	NULL
neither	NULL
AP-1-dependent	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
nor	NULL
c-fos	NULL
promoter-dependent	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
luciferase	NULL
activity	NULL
in	NULL
transfected	NULL
THP-1	NULL
cells	NULL
,	NULL
indicating	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
compound	NULL
at	NULL
the	NULL
effective	NULL
in-hibitory	NULL
concentration	NULL
.	NULL

Human	NULL
monocytes/macrophages	NULL
or	NULL
PMN	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
CAPE	NULL
at	NULL
100	NULL
pM	NULL
before	NULL
being	NULL
challenged	NULL
with	NULL
either	NULL
LAMPf	NULL
or	NULL
LPS	NULL
;	NULL
IL-8	NULL
production	NULL
was	NULL
determined	NULL
in	NULL
cell	NULL
supernatants	NULL
after	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
and	NULL
compared	NULL
to	NULL
that	NULL
in	NULL
cells	NULL
preincubated	NULL
with	NULL
the	NULL
solvent	NULL
(	NULL
DMSO	NULL
)	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
as	NULL
a	NULL
control	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
CAPE	NULL
strongly	NULL
inhibited	NULL
the	NULL
production	NULL
of	NULL
IL-8	NULL
by	NULL
either	NULL
human	NULL
monocytes/	NULL
macrophages	NULL
or	NULL
PMN	NULL
challenged	NULL
with	NULL
either	NULL
LAMPf	NULL
or	NULL
LPS	NULL
.	NULL

These	NULL
data	NULL
underscore	NULL
the	NULL
involvement	NULL
of	NULL
NF-KB	NULL
activation	NULL
in	NULL
IL-8	NULL
production	NULL
by	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
in	NULL
response	NULL
to	NULL
two	NULL
different	NULL
bacterial	NULL
stimuli	NULL
.	NULL

§§	NULL
]	NULL
NF-	NULL
«	NULL
B-luci	NULL
J	NULL
Luciferase	NULL
fold	NULL
induction	NULL
~LAMPF	NULL
+	NULL
CAPE	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
CAPE	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
transactivation	NULL
mediated	NULL
by	NULL
THP-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-	NULL
or	NULL
AP-1-driven	NULL
luciferase	NULL
(	NULL
Iuci	NULL
)	NULL
reporter	NULL
plasmid	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LAMPF	NULL
(	NULL
1	NULL
g/ml	NULL
)	NULL
for	NULL
6	NULL
h	NULL
prior	NULL
to	NULL
cell	NULL
lysis	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
assessed	NULL
in	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
(	NULL
control	NULL
[	NULL
CTRL	NULL
]	NULL
)	NULL
cells	NULL
and	NULL
normalized	NULL
to	NULL
protein	NULL
content	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
effect	NULL
of	NULL
CAPE	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
CAPE	NULL
at	NULL
the	NULL
indicated	NULL
concentration	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
LAMPFf	NULL
and	NULL
analyzed	NULL
for	NULL
luciferase	NULL
activity	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

Assays	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
data	NULL
presented	NULL
are	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

692	NULL
MARIE	NULL
ET	NULL
AL	NULL
.	NULL

100	NULL
I	NULL
vonocytes	NULL
z	NULL
;	NULL
80	NULL
D	NULL
PMN	NULL
5	NULL
7	NULL
E	NULL
5	NULL
o_	NULL
$	NULL
3	NULL
*	NULL
-	NULL
201	NULL
(	NULL
-I	NULL
al	NULL
==	NULL
4	NULL
#	NULL
F	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-specific	NULL
inhibitor	NULL
on	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
monocytes	NULL
and	NULL
PMN	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
CAPE	NULL
(	NULL
100	NULL
M	NULL
)	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

or	NULL
LAMPF	NULL
(	NULL
1	NULL
g/m	NULL
!	NULL
)	NULL

stimulation	NULL
.	NULL

DMSO	NULL
(	NULL
1	NULL
%	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
solvent	NULL
control	NULL
.	NULL

IL-8	NULL
production	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
18	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
normalized	NULL
to	NULL
cells	NULL
that	NULL
received	NULL
no	NULL
treatment	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
and	NULL
three	NULL
distinct	NULL
experiments	NULL
for	NULL
monocytes	NULL
and	NULL
PMN	NULL
,	NULL
respectively	NULL
.	NULL

DISCUSSION	NULL
Given	NULL
that	NULL
IL-8	NULL
can	NULL
play	NULL
an	NULL
major	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
a	NULL
number	NULL
of	NULL
inflammatory	NULL
diseases	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
elucidate	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
IL-8-inducers	NULL
act	NULL
on	NULL
cells	NULL
to	NULL
activate	NULL
the	NULL
production	NULL
of	NULL
this	NULL
chemokine	NULL
.	NULL

LPS	NULL
is	NULL
largely	NULL
known	NULL
to	NULL
induce	NULL
different	NULL
cell	NULL
types	NULL
to	NULL
secrete	NULL
large	NULL
amounts	NULL
of	NULL
IL-8	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
the	NULL
ability	NULL
of	NULL
another	NULL
bacterial	NULL
product	NULL
,	NULL
LAMPf	NULL
,	NULL
to	NULL
induce	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
.	NULL

The	NULL
finding	NULL
is	NULL
helpful	NULL
to	NULL
more	NULL
clearly	NULL
understand	NULL
the	NULL
pathogenic	NULL
mechanisms	NULL
of	NULL
M.	NULL
fermentans	NULL
,	NULL
a	NULL
microorganism	NULL
suspected	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
several	NULL
human	NULL
inflammatory	NULL
diseases	NULL
,	NULL
particularly	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
34	NULL
,	NULL
41	NULL
)	NULL
.	NULL

This	NULL
is	NULL
not	NULL
the	NULL
first	NULL
study	NULL
reporting	NULL
the	NULL
ability	NULL
of	NULL
mycoplasmas	NULL
to	NULL
induce	NULL
IL-8	NULL
secretion	NULL
.	NULL

M.	NULL
hominis	NULL
and	NULL
M.	NULL
salivarium	NULL
recently	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
alveolar	NULL
type	NULL
II	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
and	NULL
human	NULL
gingival	NULL
fibroblasts	NULL
(	NULL
37	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
soluble	NULL
protein	NULL
fraction	NULL
of	NULL
M.	NULL
salivarium	NULL
was	NULL
found	NULL
to	NULL
be	NULL
the	NULL
active	NULL
fraction	NULL
in	NULL
the	NULL
second	NULL
study	NULL
(	NULL
37	NULL
)	NULL
.	NULL

This	NULL
is	NULL
unusual	NULL
because	NULL
we	NULL
previously	NULL
demonstrated	NULL
that	NULL
only	NULL
Triton	NULL
X-114-fractionated	NULL
membrane	NULL
proteins	NULL
from	NULL
different	NULL
Mycoplasma	NULL
species	NULL
,	NULL
including	NULL
M.	NULL
salivarium	NULL
,	NULL
were	NULL
capable	NULL
of	NULL
inducing	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
IL-1B	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
IL-6	NULL
)	NULL
by	NULL
monocytic	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
one	NULL
can	NULL
speculate	NULL
that	NULL
Mycoplasma	NULL
species	NULL
stimulate	NULL
different	NULL
cellular	NULL
types	NULL
by	NULL
mechanisms	NULL
involving	NULL
distinct	NULL
triggering	NULL
molecular	NULL
entities	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
M.	NULL
fermentans	NULL
lipoproteins	NULL
induce	NULL
monocyte	NULL
activation	NULL
by	NULL
mechanisms	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
LPS	NULL
(	NULL
14	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
mycoplasma	NULL
membrane	NULL
lipoproteins	NULL
do	NULL
not	NULL
stimulate	NULL
monocytic	NULL
cells	NULL
via	NULL
CD14	NULL
.	NULL

Unlike	NULL
LPS	NULL
,	NULL
anti-CD14	NULL
antibodies	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
inefficient	NULL
in	NULL
blocking	NULL
the	NULL
effects	NULL
of	NULL
mycoplasma	NULL
lipoproteins	NULL
on	NULL
monocytic	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
secretion	NULL
of	NULL
IL-8	NULL
mediated	NULL
by	NULL
LAMPf	NULL
seems	NULL
also	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
CD14	NULL
,	NULL
given	NULL
that	NULL
anti-CD14	NULL
antibodies	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
this	NULL
LAMPf	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Although	NULL
LAMPFf	NULL
and	NULL
LPS	NULL
seem	NULL
to	NULL
activate	NULL
monocytes	NULL
through	NULL
distinct	NULL
cellular	NULL
membrane	NULL
receptors	NULL
,	NULL
the	NULL
signaling	NULL
triggered	NULL
by	NULL
both	NULL
agents	NULL
converts	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
MAPK	NULL
cascades	NULL
.	NULL

MAPK	NULL
pathways	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
control	NULL
of	NULL
proinflammatory	NULL
cytokine	NULL
induction	NULL
mediated	NULL
by	NULL
both	NULL
INFECT	NULL
.	NULL

ImMUN	NULL
.	NULL

LPS	NULL
and	NULL
LAMPFf	NULL
(	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Whereas	NULL
the	NULL
p38	NULL
pathway	NULL
is	NULL
crucial	NULL
in	NULL
the	NULL
signaling	NULL
leading	NULL
to	NULL
IL-1B	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
IL-6	NULL
secretion	NULL
in	NULL
macrophages	NULL
stimulated	NULL
with	NULL
LAMPf	NULL
,	NULL
ERK1/2	NULL
is	NULL
involved	NULL
in	NULL
signaling	NULL
for	NULL
synthesis	NULL
of	NULL
IL-1B	NULL
and	NULL
TNF-a	NULL
but	NULL
not	NULL
IL-6	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
involvement	NULL
of	NULL
ERK1/	NULL
2	NULL
and	NULL
p38	NULL
pathways	NULL
in	NULL
IL-8	NULL
regulation	NULL
in	NULL
both	NULL
human	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
stimulated	NULL
with	NULL
either	NULL
LPS	NULL
or	NULL
LAMPf	NULL
.	NULL

Two	NULL
inhibitors	NULL
,	NULL
PD-98059	NULL
and	NULL
$	NULL
B203580	NULL
,	NULL
that	NULL
selectively	NULL
inhibit	NULL
ERK1/2	NULL
and	NULL
p38	NULL
pathways	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
used	NULL
to	NULL
address	NULL
this	NULL
issue	NULL
.	NULL

Data	NULL
presented	NULL
herein	NULL
clearly	NULL
show	NULL
that	NULL
both	NULL
pathways	NULL
are	NULL
involved	NULL
in	NULL
IL-8	NULL
regulation	NULL
in	NULL
human	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
.	NULL

The	NULL
p38	NULL
inhibitor	NULL
,	NULL
$	NULL
B203580	NULL
,	NULL
efficiently	NULL
blocked	NULL
IL-8	NULL
production	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
in	NULL
response	NULL
to	NULL
either	NULL
LAMPf	NULL
or	NULL
LPS	NULL
,	NULL
whereas	NULL
slight	NULL
distinct	NULL
efficiency	NULL
between	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
ERK1/2	NULL
pathway	NULL
inhibitor	NULL
,	NULL
PD-98059	NULL
.	NULL

Actually	NULL
,	NULL
treatment	NULL
of	NULL
human	NULL
monocytes/macrophages	NULL
with	NULL
30	NULL
LM	NULL
PD-98059	NULL
inhibited	NULL
about	NULL
60	NULL
%	NULL
of	NULL
IL-8	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
or	NULL
LAMPf	NULL
,	NULL
whereas	NULL
this	NULL
inhibitor	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
almost	NULL
completely	NULL
blocked	NULL
IL-8	NULL
production	NULL
by	NULL
PMN	NULL
in	NULL
response	NULL
to	NULL
these	NULL
stimuli	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
ERK1/2	NULL
is	NULL
involved	NULL
in	NULL
IL-8	NULL
regulation	NULL
in	NULL
both	NULL
monocytes/macrophages	NULL
and	NULL
PMN	NULL
but	NULL
to	NULL
different	NULL
extents	NULL
.	NULL

Two	NULL
distinct	NULL
studies	NULL
have	NULL
previously	NULL
addressed	NULL
the	NULL
involvement	NULL
of	NULL
ERK1/2	NULL
and	NULL
p38	NULL
pathways	NULL
in	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
fibro-blasts	NULL
.	NULL

In	NULL
concordance	NULL
with	NULL
the	NULL
results	NULL
presented	NULL
herein	NULL
,	NULL
Bruder	NULL
and	NULL
Kovesdi	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
ERK1/2	NULL
pathway	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IL-8	NULL
in	NULL
response	NULL
to	NULL
adenovirus	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
our	NULL
data	NULL
,	NULL
Ridley	NULL
et	NULL
al	NULL
.	NULL

found	NULL
that	NULL
IL-8	NULL
production	NULL
by	NULL
human	NULL
fibroblast	NULL
in	NULL
response	NULL
to	NULL
IL-1	NULL
was	NULL
independent	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
p38	NULL
pathway	NULL
(	NULL
30	NULL
)	NULL
.	NULL

These	NULL
apparently	NULL
contradictory	NULL
results	NULL
suggest	NULL
that	NULL
IL-8	NULL
regulation	NULL
varies	NULL
from	NULL
one	NULL
cell	NULL
type	NULL
to	NULL
another	NULL
and/or	NULL
depends	NULL
on	NULL
the	NULL
stimulating	NULL
agent	NULL
.	NULL

Both	NULL
LAMPf	NULL
and	NULL
LPS	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
known	NULL
to	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
17	NULL
,	NULL
36	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Brasier	NULL
et	NULL
al	NULL
.	NULL

recently	NULL
demonstrated	NULL
by	NULL
using	NULL
an	NULL
agent	NULL
that	NULL
blocks	NULL
both	NULL
IxB	NULL
proteolysis	NULL
and	NULL
NF-kB	NULL
translocation	NULL
that	NULL
NF-kB	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-8	NULL
by	NULL
TNF-a	NULL
in	NULL
A549	NULL
alveolar	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
have	NULL
also	NULL
shown	NULL
the	NULL
involvement	NULL
of	NULL
NF-kB	NULL
in	NULL
IL-8	NULL
production	NULL
by	NULL
monocytes/macrophages	NULL
in	NULL
response	NULL
to	NULL
LAMPf	NULL
or	NULL
LPS	NULL
by	NULL
using	NULL
the	NULL
recently	NULL
described	NULL
new	NULL
NF-kB	NULL
inhibitor	NULL
CAPE	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
some	NULL
bacteria	NULL
to	NULL
induce	NULL
IL-8	NULL
can	NULL
be	NULL
considered	NULL
a	NULL
virulence	NULL
mechanism	NULL
.	NULL

Segal	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
recently	NULL
showed	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
pathogenicity	NULL
island	NULL
in	NULL
Helicobacter	NULL
pylori	NULL
correlates	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
type	NULL
I	NULL
strains	NULL
to	NULL
induce	NULL
IL-8	NULL
in	NULL
host	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
type	NULL
I	NULL
H.	NULL
pylori	NULL
associated	NULL
with	NULL
peptic	NULL
ulcer	NULL
disease	NULL
and	NULL
gastric	NULL
cancer	NULL
induces	NULL
IL-8	NULL
in	NULL
gastric	NULL
epithelial	NULL
cells	NULL
,	NULL
whereas	NULL
type	NULL
II	NULL
strains	NULL
,	NULL
more	NULL
often	NULL
associated	NULL
with	NULL
asymptomatic	NULL
gastritis	NULL
,	NULL
do	NULL
not	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Investigation	NULL
of	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
host	NULL
cell	NULL
response	NULL
to	NULL
different	NULL
bacteria	NULL
will	NULL
provide	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
pathogenesis	NULL
and	NULL
clinical	NULL
response	NULL
to	NULL
these	NULL
microorganisms	NULL
.	NULL

Although	NULL
our	NULL
findings	NULL
remain	NULL
to	NULL
be	NULL
tested	NULL
in	NULL
in	NULL
vivo	NULL
models	NULL
,	NULL
they	NULL
may	NULL
be	NULL
informative	NULL
with	NULL
respect	NULL
to	NULL
pathologies	NULL
in	NULL
which	NULL
excessive	NULL
bacterium-induced	NULL
IL-8	NULL
secretion	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
O.	NULL
Acuto	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Immunology	NULL
Moleculaire	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
reporter	NULL
plasmids	NULL
and	NULL
J.	NULL
C.	NULL
Mazié	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Hybridolab	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
and	NULL
N.	NULL
Vita	NULL
(	NULL
Sanofi	NULL
Recherche	NULL
,	NULL
Labége	NULL
,	NULL
France	NULL
)	NULL
for	NULL
providing	NULL
with	NULL
IL-8	NULL
antibodies	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
I.	NULL
Saint	NULL
Girons	NULL
for	NULL
stimulating	NULL
discussions	NULL
as	NULL
well	NULL
as	NULL
B.	NULL
Lemercier	NULL
,	NULL
A.	NULL
Dujeancourt	NULL
,	NULL
and	NULL
C.	NULL
Prevost	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

C.	NULL
Marie	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
CANAM	NULL
.	NULL

voL	NULL
.	NULL

67	NULL
,	NULL
1999	NULL
a	NULL
go	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

REFERENCES	NULL
.	NULL

Alessi	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
D.	NULL
T.	NULL
Dudley	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Saltiel	NULL
.	NULL

1995	NULL
.	NULL

PD-98059	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:27489-27494.	NULL
.	NULL

Baggiolini	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Dewald	NULL
,	NULL
and	NULL
B.	NULL
Moser	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-8	NULL
and	NULL
related	NULL
chemotactic	NULL
cytokines-CXC	NULL
and	NULL
CC	NULL
chemokines	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

55:97-179.	NULL
.	NULL

Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
E.	NULL
Milia	NULL
,	NULL
M.	NULL
M.	NULL
Di	NULL
Somma	NULL
,	NULL
F.	NULL
Baldoni	NULL
,	NULL
S.	NULL
Valitutti	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Telford	NULL
.	NULL

1995	NULL
.	NULL

Distinct	NULL
signaling	NULL
properties	NULL
identify	NULL
functionally	NULL
different	NULL
CD4	NULL
epitopes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:1843-1850.	NULL
.	NULL

Ben-Baruch	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
F.	NULL
Michiel	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1995	NULL
.	NULL

Signals	NULL
and	NULL
receptors	NULL
involved	NULL
in	NULL
recruitment	NULL
of	NULL
inflammatory	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
11703-11706.	NULL
.	NULL

Brasier	NULL
,	NULL
A.	NULL
R.	NULL
1994	NULL
.	NULL

Reporter	NULL
system	NULL
using	NULL
firefly	NULL
luciferase	NULL
,	NULL
p.	NULL
9.6.1-9.6.14	NULL
.	NULL

In	NULL
F.	NULL
M.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Strubl	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

Green	NULL
Publishing	NULL
and	NULL
John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
.	NULL

Brasier	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
M.	NULL
Jamaluddin	NULL
,	NULL
A.	NULL
Casola	NULL
,	NULL
W.	NULL
Duan	NULL
,	NULL
Q.	NULL
Shen	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
Garofalo	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
promoter	NULL
recruitment	NULL
mechanism	NULL
for	NULL
tumor	NULL
necrosis	NULL
factor-alpha-induced	NULL
interleukin-8	NULL
transcription	NULL
in	NULL
type	NULL
II	NULL
pulmonary	NULL
epithelial	NULL
cells	NULL
.	NULL

Dependence	NULL
on	NULL
nuclear	NULL
abundance	NULL
of	NULL
Rel	NULL
A	NULL
,	NULL
NF-	NULL
«	NULL
B1	NULL
,	NULL
and	NULL
c-Rel	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:3551-3561.	NULL
.	NULL

Bruder	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
I.	NULL
Kovesdi	NULL
.	NULL

1997	NULL
.	NULL

Adenovirus	NULL
infection	NULL
stimulates	NULL
the	NULL
Raf/MAPK	NULL
signaling	NULL
pathway	NULL
and	NULL
induces	NULL
interleukin-8	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:398-404.	NULL
.	NULL

Cacalano	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Lee	NULL
,	NULL
K.	NULL
Kikly	NULL
,	NULL
A.	NULL
M.	NULL
Ryan	NULL
,	NULL
S.	NULL
Pitts-Meek	NULL
,	NULL
B.	NULL
Hultgren	NULL
,	NULL
W.	NULL
I	NULL
.	NULL

Wood	NULL
,	NULL
and	NULL
M.	NULL
W.	NULL
Moore	NULL
.	NULL

1994	NULL
.	NULL

Neutrophil	NULL
and	NULL
B	NULL
cell	NULL
expansion	NULL
in	NULL
mice	NULL
that	NULL
lack	NULL
the	NULL
murine	NULL
IL-8	NULL
receptor	NULL
homolog	NULL
.	NULL

Science	NULL
265:682-684.	NULL
.	NULL

Cavaillon	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.	NULL
Marie	NULL
,	NULL
C.	NULL
Pitton	NULL
,	NULL
and	NULL
C.	NULL
Fitting	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
production	NULL
of	NULL
TNFa	NULL
and	NULL
IL-8	NULL
in	NULL
whole	NULL
blood	NULL
assays	NULL
are	NULL
differently	NULL
regulated	NULL
aupon	NULL
activation	NULL
by	NULL
LPS	NULL
.	NULL

Prog	NULL
.	NULL

Clin	NULL
.	NULL

Biol	NULL
.	NULL

Res	NULL
.	NULL

392:433-439	NULL
.	NULL

DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
J.	NULL
Hambleton	NULL
,	NULL
M.	NULL
McMahon	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Weinstein	NULL
.	NULL

1995	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
role	NULL
of	NULL
MAP	NULL
kinase	NULL
in	NULL
the	NULL
response	NULL
of	NULL
macrophages	NULL
to	NULL
lipopolysaccharide	NULL
.	NULL

Prog	NULL
.	NULL

Clin	NULL
.	NULL

Biol	NULL
.	NULL

Res	NULL
.	NULL

392:407-420	NULL
.	NULL

Dudley	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
L.	NULL
Pang	NULL
,	NULL
S.	NULL
J.	NULL
Decker	NULL
,	NULL
A.	NULL
J.	NULL
Bridges	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Saltiel	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
synthetic	NULL
inhibitor	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7686-7689	NULL
.	NULL

Geng	NULL
,	NULL
Y.	NULL
,	NULL
B.	NULL
Zhang	NULL
,	NULL
and	NULL
M.	NULL
Lotz	NULL
.	NULL

1993	NULL
.	NULL

Protein	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
lipopolysaccharide	NULL
induction	NULL
of	NULL
cytokines	NULL
in	NULL
human	NULL
blood	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:6692-6700	NULL
.	NULL

Koch	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
P.	NULL
J.	NULL
Polverini	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
L.	NULL
A.	NULL
Harlow	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

Di	NULL
Pietro	NULL
,	NULL
V.	NULL
M.	NULL
Elner	NULL
,	NULL
S.	NULL
G.	NULL
Elner	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Strieter	NULL
.	NULL

1992	NULL
.	NULL

Interleukin-8	NULL
as	NULL
a	NULL
macrophage-derived	NULL
mediator	NULL
of	NULL
angiogenesis	NULL
.	NULL

Science	NULL
258:1798-1801	NULL
.	NULL

Kostyal	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
G.	NULL
H.	NULL
Butler	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Beezhold	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
48-kilodalton	NULL
Mycoplasma	NULL
fermentans	NULL
membrane	NULL
protein	NULL
induces	NULL
cytokine	NULL
secretion	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:3793-3800	NULL
.	NULL

Kruger	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
J.	NULL
Baier	NULL
.	NULL

1997	NULL
.	NULL

Induction	NULL
of	NULL
neutrophil	NULL
chemoattractant	NULL
cytokines	NULL
by	NULL
Mycoplasma	NULL
hominis	NULL
in	NULL
alveolar	NULL
type	NULL
II	NULL
cells	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

65	NULL
:	NULL
5131-5136	NULL
.	NULL

Lee	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
J.	NULL
T.	NULL
Laydon	NULL
,	NULL
P.	NULL
C.	NULL
McDonnell	NULL
,	NULL
T.	NULL
F.	NULL
Gallagher	NULL
,	NULL
S.	NULL
Kumar	NULL
,	NULL
D.	NULL
Green	NULL
,	NULL
D.	NULL
McNulty	NULL
,	NULL
M.	NULL
J.	NULL
Blumenthal	NULL
,	NULL
J.	NULL
R.	NULL
Heys	NULL
,	NULL
S.	NULL
W.	NULL
Landvatter	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
protein	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
biosynthesis	NULL
.	NULL

Nature	NULL
372:739-746	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2327-2334	NULL
.	NULL

Manthey	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
N.	NULL
Vogel	NULL
.	NULL

1994	NULL
.	NULL

Interactions	NULL
of	NULL
lipopolysaccharide	NULL
with	NULL
macrophages	NULL
.	NULL

Immunol	NULL
.	NULL

Ser	NULL
.	NULL

60:63-81	NULL
.	NULL

Marie	NULL
,	NULL
C.	NULL
,	NULL
M.-R.	NULL
Losser	NULL
,	NULL
C.	NULL
Fitting	NULL
,	NULL
N.	NULL
Kermarrec	NULL
,	NULL
D.	NULL
Payen	NULL
,	NULL
and	NULL
J.-M.	NULL
Cavaillon	NULL
.	NULL

1997	NULL
.	NULL

Cytokines	NULL
and	NULL
soluble	NULL
cytokine	NULL
receptors	NULL
in	NULL
pleural	NULL
effusions	NULL
from	NULL
septic	NULL
and	NULL
nonseptic	NULL
patients	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

156:1-8	NULL
.	NULL

Marie	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Pitton	NULL
,	NULL
C.	NULL
Fitting	NULL
,	NULL
and	NULL
J.-M.	NULL
Cavaillon	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
by	NULL
anti-inflammatory	NULL
cytokines	NULL
(	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IL-13	NULL
,	NULL
TGFB	NULL
)	NULL
of	NULL
interleukin-8	NULL
production	NULL
by	NULL
LPS-	NULL
and/or	NULL
TNFa-activated	NULL
human	NULL
polymorphonuclear	NULL
cells	NULL
.	NULL

Mediators	NULL
Inflamm	NULL
.	NULL

5:334-340	NULL
.	NULL

Marty	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Misset	NULL
,	NULL
F.	NULL
Tamion	NULL
,	NULL
C.	NULL
Fitting	NULL
,	NULL
J.	NULL
Carlet	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Cavaillon	NULL
.	NULL

1994	NULL
.	NULL

Circulating	NULL
interleukin-8	NULL
concentrations	NULL
in	NULL
patients	NULL
with	NULL
multiple	NULL
organ	NULL
failure	NULL
of	NULL
septic	NULL
and	NULL
nonseptic	NULL
origin	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

22:673-679	NULL
.	NULL

Matsushima	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Morishita	NULL
,	NULL
T.	NULL
Yoshimura	NULL
,	NULL
S.	NULL
Layu	NULL
,	NULL
Y.	NULL
Kobayashi	NULL
,	NULL
W.	NULL
Lew	NULL
,	NULL
E.	NULL
Appella	NULL
,	NULL
H.	NULL
F.	NULL
Kung	NULL
,	NULL
E.	NULL
J.	NULL
Leonard	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1988	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
human	NULL
monocyte-derived	NULL
neutrophil	NULL
chemotactic	NULL
factor	NULL
(	NULL
MDNCF	NULL
)	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
MDNCF	NULL
mRNA	NULL
by	NULL
interleukin	NULL
1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167:1883-1893	NULL
.	NULL

Miller	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangel	NULL
.	NULL

1992	NULL
.	NULL

Biology	NULL
and	NULL
biochemistry	NULL
of	NULL
the	NULL
chemokines	NULL
:	NULL
a	NULL
family	NULL
of	NULL
chemotactic	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:17-46	NULL
.	NULL

Munoz	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Carlet	NULL
,	NULL
C.	NULL
Fitting	NULL
,	NULL
B.	NULL
Misset	NULL
,	NULL
J.	NULL
P.	NULL
Bleriot	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Cavaillon	NULL
.	NULL

Editor	NULL
:	NULL
J.	NULL
R.	NULL
McGhee	NULL
INVOLVEMENT	NULL
OF	NULL
MAPK	NULL
PATHWAYS	NULL
IN	NULL
IL-8	NULL
PRODUCTION	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

693	NULL
1991	NULL
.	NULL

Dysregulation	NULL
of	NULL
in	NULL
vitro	NULL
cytokine	NULL
production	NULL
by	NULL
monocytes	NULL
during	NULL
sepsis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Investig	NULL
.	NULL

88:1747-1754	NULL
.	NULL

Natarajan	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Singh	NULL
,	NULL
T.	NULL
Burke	NULL
,	NULL
D.	NULL
Grunberger	NULL
,	NULL
and	NULL
B	NULL
.	NULL

B.	NULL
Aggarwal	NULL
.	NULL

1996	NULL
.	NULL

Caffeic	NULL
acid	NULL
phenethyl	NULL
ester	NULL
is	NULL
a	NULL
potent	NULL
and	NULL
specific	NULL
inhibitor	NULL
of	NULL
activation	NULL
of	NULL
nuclear	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9090-9095	NULL
.	NULL

Rawadi	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
Lecaque	NULL
,	NULL
D.	NULL
Pirot	NULL
,	NULL
and	NULL
S.	NULL
Roman-Roman	NULL
.	NULL

1993	NULL
.	NULL

Detection	NULL
and	NULL
identification	NULL
of	NULL
mycoplasma	NULL
contaminating	NULL
cell	NULL
cultures	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Methods	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

4:147-156	NULL
.	NULL

Rawadi	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Morvan	NULL
,	NULL
B.	NULL
Lemercier	NULL
,	NULL
and	NULL
S.	NULL
Roman-Roman	NULL
.	NULL

1998	NULL
.	NULL

Activation	NULL
of	NULL
MAPK	NULL
pathways	NULL
by	NULL
Mycoplasma	NULL
fermentans	NULL
membrane	NULL
lipoproteins	NULL
in	NULL
murine	NULL
macrophages	NULL
:	NULL
involvement	NULL
in	NULL
cytokine	NULL
synthesis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160	NULL
:	NULL
1330-1339	NULL
.	NULL

Rawadi	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
S.	NULL
Roman-Roman	NULL
.	NULL

1996	NULL
.	NULL

Mycoplasma	NULL
membrane	NULL
lipoproteins	NULL
induced	NULL
proinflammatory	NULL
cytokines	NULL
by	NULL
a	NULL
mechanism	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
lipopolysaccharide	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

64:637-643	NULL
.	NULL

Rawadi	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Roman-Roman	NULL
,	NULL
M.	NULL
Castedo	NULL
,	NULL
V.	NULL
Dutilleul	NULL
,	NULL
S.	NULL
Susin	NULL
,	NULL
P.	NULL
Mar-chetti	NULL
,	NULL
M.	NULL
Geuskens	NULL
,	NULL
and	NULL
G.	NULL
Kroemer	NULL
.	NULL

1996	NULL
.	NULL

Effects	NULL
of	NULL
Mycoplasma	NULL
fermentans	NULL
on	NULL
the	NULL
myelomonocytic	NULL
lineage	NULL
.	NULL

Different	NULL
molecular	NULL
entities	NULL
with	NULL
cyto-kine-inducing	NULL
and	NULL
cytocidal	NULL
potential	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:670-678	NULL
.	NULL

29a.Rawadi	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
B.	NULL
Lemercier	NULL
,	NULL
and	NULL
S.	NULL
Roman-Roman	NULL
.	NULL

Signal	NULL
trans-	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46.	NULL
duction	NULL
pathways	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
c-fos	NULL
by	NULL
Mycoplasma	NULL
fermentans	NULL
lipoproteins	NULL
in	NULL
macrophages	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Ridley	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
S.	NULL
J.	NULL
Sarsfield	NULL
,	NULL
J.	NULL
C.	NULL
Lee	NULL
,	NULL
H.	NULL
F.	NULL
Bigg	NULL
,	NULL
T.	NULL
E.	NULL
Cawston	NULL
,	NULL
D.	NULL
J.	NULL
Taylor	NULL
,	NULL
D.	NULL
L.	NULL
DeWitt	NULL
,	NULL
and	NULL
J.	NULL
Saklatvala	NULL
.	NULL

1997	NULL
.	NULL

Actions	NULL
of	NULL
IL-1	NULL
are	NULL
selectively	NULL
controlled	NULL
by	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
:	NULL
regulation	NULL
of	NULL
prostaglan-din	NULL
H	NULL
synthase-2	NULL
,	NULL
metalloproteinases	NULL
,	NULL
and	NULL
IL-6	NULL
at	NULL
different	NULL
levels	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:3165-3173	NULL
.	NULL

Rodwell	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
and	NULL
R.	NULL
F.	NULL
Whitcomb	NULL
.	NULL

1983	NULL
.	NULL

Mcthods	NULL
for	NULL
direct	NULL
and	NULL
indirect	NULL
measurement	NULL
of	NULL
mycoplasma	NULL
growth	NULL
,	NULL
p.	NULL
185-196	NULL
.	NULL

In	NULL
S.	NULL
Razin	NULL
and	NULL
J.	NULL
H.	NULL
Tully	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Methods	NULL
in	NULL
mycoplasmology	NULL
,	NULL
vol	NULL
.	NULL

4	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
Rollins	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Chemokines	NULL
.	NULL

Blood	NULL
90:909-928	NULL
.	NULL

Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
S.	NULL
L	NULL
Weinstein	NULL
,	NULL
M.	NULL
Aluwalia	NULL
,	NULL
J.	NULL
Girn	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Pelech	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
multiple	NULL
proline-directed	NULL
kinases	NULL
by	NULL
bacterial	NULL
lipopolysaccharide	NULL
in	NULL
murine	NULL
macrophages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:4457-4465	NULL
.	NULL

Schaeverbeke	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
B.	NULL
Gilroy	NULL
,	NULL
C.	NULL
Bebear	NULL
,	NULL
J.	NULL
Dehais	NULL
,	NULL
and	NULL
D.	NULL
Taylor-Robin-son	NULL
.	NULL

1996	NULL
.	NULL

Mycoplasma	NULL
fermentans	NULL
,	NULL
but	NULL
not	NULL
M.	NULL
penetrans	NULL
,	NULL
detected	NULL
by	NULL
PCR	NULL
assays	NULL
in	NULL
synovium	NULL
from	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
other	NULL
rheumatic	NULL
disorders	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Pathol	NULL
.	NULL

49:824-828	NULL
.	NULL

Segal	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
C.	NULL
Lange	NULL
,	NULL
A.	NULL
Covacci	NULL
,	NULL
L.	NULL
S.	NULL
Tompkins	NULL
,	NULL
and	NULL
S.	NULL
Falkow	NULL
.	NULL

1997	NULL
.	NULL

Induction	NULL
of	NULL
host	NULL
signal	NULL
transduction	NULL
pathways	NULL
by	NULL
Helicobacter	NULL
pylori	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:7595-7599	NULL
.	NULL

Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
M.	NULL
A.	NULL
Collart	NULL
,	NULL
P.	NULL
Vassalli	NULL
,	NULL
S.	NULL
A.	NULL
Nedospasov	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1990	NULL
.	NULL

NF-	NULL
«	NULL
B-type	NULL
enhancers	NULL
are	NULL
involved	NULL
in	NULL
lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
gene	NULL
in	NULL
primary	NULL
macrophages	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:35-47	NULL
.	NULL

Shibata	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
Hasebe	NULL
,	NULL
T.	NULL
Sasaki	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1998	NULL
.	NULL

Mycoplasma	NULL
salivarium	NULL
induces	NULL
interleukin-6	NULL
and	NULL
interleukin-8	NULL
in	NULL
human	NULL
gingival	NULL
fibro-blasts	NULL
.	NULL

FEMS	NULL
Immunol	NULL
.	NULL

Med	NULL
.	NULL

Microbiol	NULL
.	NULL

19:275-283	NULL
.	NULL

Stacey	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
I.	NULL
L.	NULL
Ross	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Hume	NULL
.	NULL

1993	NULL
.	NULL

Electroporation	NULL
and	NULL
DNA-dependent	NULL
cell	NULL
death	NULL
in	NULL
murine	NULL
macrophages	NULL
.	NULL

Immunol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

71:75-85	NULL
.	NULL

Strieter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Koch	NULL
,	NULL
V.	NULL
B.	NULL
Antony	NULL
,	NULL
R.	NULL
B.	NULL
Fick	NULL
,	NULL
Jr.	NULL
,	NULL
T.	NULL
J.	NULL
Standiford	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Kunkel	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
immunopathology	NULL
of	NULL
chemotactic	NULL
cytokines	NULL
:	NULL
the	NULL
role	NULL
of	NULL
interleukin-8	NULL
and	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
.	NULL

J	NULL
.	NULL

Lab	NULL
.	NULL

Clin	NULL
.	NULL

Med	NULL
.	NULL

123:183-197	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Mitogen-activated	NULL
protein	NULL
kinase	NULL
cascades	NULL
and	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:402-411	NULL
.	NULL

Taylor-Robinson	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Schaeverbeke	NULL
.	NULL

1996	NULL
.	NULL

Mycoplasmas	NULL
in	NULL
theuma-toid	NULL
arthritis	NULL
and	NULL
other	NULL
human	NULL
arthritides	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Pathol	NULL
.	NULL

49:781-782	NULL
.	NULL

Wise	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Kim	NULL
.	NULL

1987	NULL
.	NULL

Major	NULL
membrane	NULL
surface	NULL
proteins	NULL
of	NULL
Mycoplasma	NULL
hyopneumoniae	NULL
selectively	NULL
modified	NULL
by	NULL
covalently	NULL
bound	NULL
lipid	NULL
.	NULL

J.	NULL
Bacteriol	NULL
.	NULL

169:5546-5555	NULL
.	NULL

Wulezyn	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
D.	NULL
Krappmann	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
NK-	NULL
«	NULL
B/Rel	NULL
and	NULL
IxB	NULL
gene	NULL
families	NULL
:	NULL
mediators	NULL
of	NULL
immune	NULL
response	NULL
and	NULL
inflammation	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Med	NULL
.	NULL

74:749-769	NULL
.	NULL

Yao	NULL
,	NULL
J.	NULL
,	NULL
N.	NULL
Mackman	NULL
,	NULL
T.	NULL
S.	NULL
Edgington	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Fan	NULL
.	NULL

1997	NULL
.	NULL

Lipopolysaccharide	NULL
induction	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
promoter	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

Regulation	NULL
by	NULL
Egr-1	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:17795-17801	NULL
.	NULL

Ye	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
and	NULL
B.	NULL
D.	NULL
Clark	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
human	NULL
interleukin	NULL
1	NULL
type	NULL
I	NULL
receptor	NULL
gene	NULL
:	NULL
multiple	NULL
initiation	NULL
sites	NULL
,	NULL
high	NULL
G+C	NULL
content	NULL
,	NULL
and	NULL
constitutive	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2295-2299	NULL
.	NULL

Yoshimura	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Neutrophil	NULL
chemotactic	NULL
factor	NULL
produced	NULL
by	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-stim-ulated	NULL
human	NULL
blood	NULL
mononuclear	NULL
leukocytes	NULL
:	NULL
partial	NULL
characterization	NULL
and	NULL
separation	NULL
from	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:788-793	NULL
.	NULL

